Interaction between androgen receptor and p52 factor (engaged in noncanonical NF-κB pathway activation) promotes prostate cancer cell growth, protects from apoptotic cell death, and influences expression of androgen receptor dependent genes [28–31]. This evidence concerns the gene AR and prostate carcinoma.